Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

460 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
P glycoprotein in human immunodeficiency virus type 1 infection and therapy.
Sankatsing SU, Beijnen JH, Schinkel AH, Lange JM, Prins JM. Sankatsing SU, et al. Among authors: lange jm. Antimicrob Agents Chemother. 2004 Apr;48(4):1073-81. doi: 10.1128/AAC.48.4.1073-1081.2004. Antimicrob Agents Chemother. 2004. PMID: 15047504 Free PMC article. Review. No abstract available.
Antiviral activity of HIV type 1 protease inhibitors nelfinavir and indinavir in vivo is not influenced by P-glycoprotein activity on CD4+ T cells.
Sankatsing SU, Cornelissen M, Kloosterboer N, Crommentuyn KM, Bosch TM, Mul FP, Jurriaans S, Huitema AD, Beijnen JH, Lange JM, Prins JM, Schuitemaker H. Sankatsing SU, et al. Among authors: lange jm. AIDS Res Hum Retroviruses. 2007 Jan;23(1):19-27. doi: 10.1089/aid.2006.0027. AIDS Res Hum Retroviruses. 2007. PMID: 17263628
The pharmacokinetics of nelfinavir in HIV-1-infected children.
van Heeswijk RP, Scherpbier HJ, de Koning LA, Heymans HS, Lange JM, Beijnen JH, Hoetelmans RM. van Heeswijk RP, et al. Among authors: lange jm. Ther Drug Monit. 2002 Aug;24(4):487-91. doi: 10.1097/00007691-200208000-00004. Ther Drug Monit. 2002. PMID: 12142631 Clinical Trial.
Simplifying protease inhibitor therapy with once-daily dosing of saquinavir soft-gelatin capsules/ritonavir (1600/100 mg): HIVNAT 001.3 study.
Cardiello PG, van Heeswijk RP, Hassink EA, Srasuebkul P, Mahanontharit A, Samor TM, Worarien W, Beijnen JH, Hoetelmans RM, Ruxrungtham K, Cooper DA, Lange JM, Phanuphak P. Cardiello PG, et al. Among authors: lange jm. J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):464-70. doi: 10.1097/00042560-200204150-00006. J Acquir Immune Defic Syndr. 2002. PMID: 11981362 Clinical Trial.
460 results